CW June 2005
Volume 14Issue Number 6 June 2005 ISSN 10593802 Can Genetics Guide Drug Choice in Prostate Cancer?In the not-too-distant future, drug therapy for prostate cancer may be guided by a patient?s genetically-determined metabolic predispositions, reported Avi Retter, at the Annual Meeting of the American Urological Association.
Go to Previous Page Go to Next Page Source & Additional Reading Avi Retter et al., at the Annual Meeting of the American Urological Association. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
